Alcidion Group Ltd - Strategy, SWOT and Corporate Finance Report
Summary
Alcidion Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Alcidion Group Ltd (Alcidion) is a health informatics company which designs, develops, and implements smart software solutions and services for healthcare organizations and hospitals. The company's product portfolio includes health informatics platforms such as Miya Precision, Patientrack, Silverlink PCS, ExtraMed, and Smartpage. Its health informatics platforms incorporates clinical decision support engine, electronic medical records (EMR), data integration, terminology support, standard-based web services, and electronic smart forms. The company has operations in Australia, the UK, and New Zealand. Alcidion is headquartered in South Yarra, Victoria, Australia.
Scope
Detailed information on Alcidion Group Ltd required for business and competitor intelligence needs
A study of the major internal and external factors affecting Alcidion Group Ltd in the form of a SWOT analysis
An in-depth view of the business model of Alcidion Group Ltd including a breakdown and examination of key business segments
Intelligence on Alcidion Group Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Alcidion Group Ltd, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Alcidion Group Ltd and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Alcidion Group Ltd as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Alcidion Group Ltd's business structure, strategy and prospects.
COMPANY OVERVIEW AND KEY FACTS
TARGETS AND PARTNERS
MERGERS & ACQUISITIONS
Mergers and Acquisitions - Overview
Mergers and Acquisitions - Deal reports
PARTNERSHIP
Partnership - Overview
Partnership - Deal reports
CAPITAL RAISING
Capital Raising - Overview
Capital Raising - Deal reports
PRIVATE EQUITY & OWNERSHIP
Private Equity and Ownership - Overview
Private Equity and Ownership - Deal reports
APPENDIX
Contact Us
About MarketLine Financial Deals Database
Deal Definition and Methodology
About MarketLine
List of Tables
Table 1: Aldeyra Therapeutics Inc M&A volume and value trend (2019-YTD2023)
Table 2: Aldeyra Therapeutics Inc M&A activity by geography (2019-YTD2023)
Table 3: Aldeyra Therapeutics Inc partnership volume and value trend (2019-YTD2023)
Table 4: Aldeyra Therapeutics Inc partnership trend by key deal type (2019-YTD2023)
Table 5: Aldeyra Therapeutics Inc capital raising volume and value trend (2019-YTD2023)
Table 6: Aldeyra Therapeutics Inc capital raising by deal type (2019-YTD2023)
Table 7: Aldeyra Therapeutics Inc private equity and ownership volume and value trend (2019-YTD2023)
Table 8: Aldeyra Therapeutics Inc private equity and ownership activity by deal type (2019-YTD2023)
List of Figures
Figure 1: Aldeyra Therapeutics Inc M&A volume and value trend (2019-YTD2023)
Figure 2: Aldeyra Therapeutics Inc M&A activity by geography (2019-YTD2023)
Figure 3: Aldeyra Therapeutics Inc partnership volume and value trend (2019-YTD2023)
Figure 4: Aldeyra Therapeutics Inc partnership trend by key deal type (2019-YTD2023)
Figure 5: Aldeyra Therapeutics Inc capital raising volume and value trend (2019-YTD2023)
Figure 6: Aldeyra Therapeutics Inc capital raising by deal type (2019-YTD2023)
Figure 7: Aldeyra Therapeutics Inc private equity and ownership volume and value trend (2019-YTD2023)
Figure 8: Aldeyra Therapeutics Inc private equity and ownership by deal type (2019-YTD2023)